0001179110-14-001313.txt : 20140123
0001179110-14-001313.hdr.sgml : 20140123
20140123170110
ACCESSION NUMBER: 0001179110-14-001313
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140121
FILED AS OF DATE: 20140123
DATE AS OF CHANGE: 20140123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICINES CO /DE
CENTRAL INDEX KEY: 0001113481
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043324394
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-290-6000
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICINES CO/ MA
DATE OF NAME CHANGE: 20000504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Antinori Paul Michael
CENTRAL INDEX KEY: 0001318459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31191
FILM NUMBER: 14543595
MAIL ADDRESS:
STREET 1: THE MEDICINES COMPANY
STREET 2: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
edgar.xml
FORM 4 -
X0306
4
2014-01-21
0
0001113481
MEDICINES CO /DE
MDCO
0001318459
Antinori Paul Michael
8 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Sr. VP & General Counsel
Common Stock
2014-01-21
4
M
0
10500
7.31
A
41912
D
Common Stock
2014-01-21
4
S
0
10500
38.0024
D
31412
D
Common Stock
2014-01-21
4
M
0
20000
14.82
A
51412
D
Common Stock
2014-01-21
4
S
0
20000
38.0907
D
31412
D
Common Stock
2014-01-21
4
M
0
7000
17.45
A
38412
D
Common Stock
2014-01-21
4
S
0
7000
37.8171
D
31412
D
Common Stock
2014-01-21
4
S
0
383
38.0526
D
31029
D
Stock Option (right-to-buy)
7.31
2014-01-21
4
M
0
10500
D
2020-02-19
Common Stock
10500
2000
D
Stock Option (right-to-buy)
14.82
2014-01-21
4
M
0
20000
D
2020-09-17
Common Stock
20000
8330
D
Stock Option (right-to-buy)
17.45
2014-01-21
4
M
0
7000
D
2021-02-18
Common Stock
7000
6333
D
The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on December 13, 2013.
Represents the weighted average sales price of the shares sold ranging from a low of $37.77 to a high of $38.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $37.72 to a high of $38.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $37.70 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $38.05 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option vests in forty-eight equal monthly installments beginning on March 19, 2010.
This option vests in forty-eight equal monthly installments beginning October 17, 2010.
This option vests in forty-eight equal monthly installments beginning on March 18, 2011.
Not applicable.
/s/ Paul M. Antinori
2014-01-23